Informations:
Erreur:
ID
20437
Description
Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00898014
Lien
https://clinicaltrials.gov/show/NCT00898014
Mots-clés
Versions (1)
- 22/02/2017 22/02/2017 -
Téléchargé le
22 février 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Breast Cancer NCT00898014
Eligibility Breast Cancer NCT00898014
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00898014
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
breast carcinoma, tumor stage
Item
diagnosis of stage iv breast cancer
boolean
C0678222 (UMLS CUI [1,1])
C1300072 (UMLS CUI [1,2])
C1300072 (UMLS CUI [1,2])
measurable or evaluable disease
Item
measurable or evaluable disease
boolean
C1513041 (UMLS CUI [1])
C1516986 (UMLS CUI [2])
C1516986 (UMLS CUI [2])
First line treatment; Chemotherapy Regimen | Breast Carcinoma; HER2/Neu Status | trastuzumab
Item
scheduled to receive first-line chemotherapy with or without trastuzumab (herceptin®), depending on her-2 status
boolean
C1708063 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2,1])
C1512413 (UMLS CUI [2,2])
C0728747 (UMLS CUI [3])
C0392920 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2,1])
C1512413 (UMLS CUI [2,2])
C0728747 (UMLS CUI [3])
histological diagnosis, her2 status
Item
histologic block available for confirming pathologic diagnosis and measuring her-2 status via fish
boolean
C0679557 (UMLS CUI [1])
C1512413 (UMLS CUI [2])
C1512413 (UMLS CUI [2])
characteristics
Item
patient characteristics:
boolean
C1521970 (UMLS CUI [1])
life expectancy
Item
life expectancy > 3 months
boolean
C0023671 (UMLS CUI [1])
History of neoplastic disease | Basal cell carcinoma | Carcinoma in situ of uterine cervix
Item
no other cancer in the past 5 years except for basal cell skin cancer or epithelial in situ cancer of the cervix
boolean
C2735088 (UMLS CUI [1])
C0007117 (UMLS CUI [2])
C0851140 (UMLS CUI [3])
C0007117 (UMLS CUI [2])
C0851140 (UMLS CUI [3])
Protocol Compliance; Limited (extensiveness)
Item
no geographic, social, or psychiatric reasons that would make treatment impossible
boolean
C0525058 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,2])
prior concurrent therapy
Item
prior concurrent therapy:
boolean
C1514463 (UMLS CUI [1,1])
C0009429 (UMLS CUI [1,2])
C0009429 (UMLS CUI [1,2])
prior chemotherapy for metastatic disease
Item
no prior chemotherapy for metastatic disease
boolean
C1514457 (UMLS CUI [1,1])
C2939420 (UMLS CUI [1,2])
C2939420 (UMLS CUI [1,2])